查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1980185

畜牧疫苗市场规模、份额、成长率及全球市场分析：按类型、应用和地区划分，并预测至2026-2034年

Livestock Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 150 Pages | 商品交期: 请询问到货日

价格

畜牧疫苗市场成长要素

全球畜牧疫苗市场预计在2025年达到63.3亿美元，2026年成长至66.8亿美元，并在2034年达到113.9亿美元，预测期内复合年增长率（CAGR）为6.9%。北美地区在2025年将占据市场主导地位，市场份额达46.90%，这主要得益于其大规模的畜牧存栏量、政府主导的疫苗接种计划以及先进疫苗的普及。预计到2032年，美国畜牧疫苗市场规模将达到42.9亿美元，主要得益于持续的研发投入以及政府为改善动物健康而采取的各项措施。

市场概览

畜禽疫苗在保护牲畜免受口蹄疫、牛传染性鼻气管炎（IBR）、新城疫和猪繁殖与呼吸综合症（PRRS）等感染疾病发挥着至关重要的作用。疫苗可透过多种途径接种，包括注射、口服、鼻腔和皮下注射，并有多种形式，包括减毒活病毒疫苗疫苗、不活化疫苗、重组疫苗和类毒素疫苗。这些疫苗有助于减少与牲畜疾病相关的经济损失，并保障全球粮食安全。

市场驱动因素

通用病的日益流行推动了市场成长，这些感染疾病可从动物传染给人类。这迫使各国政府和畜牧业主实施预防性疫苗接种计画。在美国，每年约有5000例动物狂犬病病例报告，其中超过90%发生在野生动物身上，凸显了畜牧疫苗的迫切需求。农民对动物保健和疫苗接种益处的认识不断提高，也促进了市场成长。

主要企业的研发投入也正在推动市场扩张。各公司正投资开发先进疫苗，例如蛋白质次单元疫苗和重组疫苗，以应对新出现的感染疾病并增强牲畜的免疫反应。例如，勃林格殷格翰公司推出了VAXXITEK HVT+IBD+ILT，这是一种用于预防家禽马立克氏病、传染性咽炎腱鞘炎和传染性喉气管炎的重组疫苗。

市场限制因素

儘管市场存在成长机会，但疫苗相关副作用也为市场带来了挑战。减毒活疫苗有时会引起轻微反应，某些疫苗对目标疾病的有效性可能有限。这些问题可能会降低畜牧养殖户的疫苗采用率，并减缓部分地区的市场成长。

市场区隔

按类型：

  • 到 2026 年，减毒活病毒疫苗将占据市场主导地位，占市场份额的 38.93%，这得益于其强大而持久的免疫反应。
  • 受家禽和猪病防治领域创新和日益普及的推动，重组疫苗预计将在 2026 年至 2034 年间实现最高的复合年增长率。
  • 灭活疫苗和其他类型的疫苗也促进了市场成长。

动物种类：

  • 到 2026 年，在全球牛数量增长的推动下，牛疫苗将占据最大的市场份额，达到 58%。
  • 由于疾病爆发的蔓延，预计 2025 年至 2032 年间，家禽疫苗的复合年增长率将最高。
  • 由于猪繁殖与呼吸综合症（PRRS）和猪流感的爆发，猪疫苗继续发挥重要作用。

依管理途径：

  • 到 2026 年，能够提供可靠免疫反应和快速疗效的注射疫苗将占最大份额，达到 67.16%。
  • 由于技术创新和临床试验的增加，口服疫苗正在发展壮大。
  • 其他给药途径，如鼻内给药，仅限于特定用途。

按分销管道：

  • 到 2024 年，动物医院将占据市场主导地位，由于牲畜患者数量增加和兽医招聘成功，它们将继续保持主导地位。
  • 兽医院正在扩张，特别是疫苗接种后的护理。

区域趋势

北美：预计2025年市场规模将达29.7亿美元，2026年将达31.3亿美元。这主要得益于疫苗的上市、先进产品的应用以及大规模的牲畜存栏量。美国市场预计2026年将达29亿美元。

欧洲：市场预计将稳定成长，主要受家禽和生猪引进、通用感染疾病传播以及政府宣传宣传活动的影响。预计到2026年，英国和德国市场规模将分别达到2.4亿美元和3.3亿美元。

亚太地区：受中国、印度和日本疫苗接种计划和宣传活动的推动，该地区预计将实现最高的复合年增长率。预计2026年，日本市场规模将达2.5亿美元，中国为2.8亿美元，印度为1亿美元。

拉丁美洲、中东和非洲：由于牲畜疾病的增加、疫苗技术的引入以及动物保健基础设施的发展，市场份额正在扩大。

主要市场参与者

主要企业包括硕腾服务有限公司（Zoetis Services LLC）、默克动物保健（Merck Animal Health）、勃林格殷格翰国际有限公司（Boehringer Ingelheim International GmbH）、维克（Virbac）、西瓦（Ceva）、礼来（Elanco）和HIPRA。这些公司正致力于研发、新产品上市、併购和市场扩张，以巩固其全球地位。诸如伙伴关係、收购和新疫苗研发等策略性措施是确立市场领导地位的关键。

目录

第一章：引言

第二章执行摘要

第三章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第四章：主要考虑因素

  • 动物疫苗接种率：主要条件
  • 免疫接种计划概述
  • 产业重大发展、合併、收购及合作。
  • 新冠疫情的影响：畜牧疫苗市场

第五章：2021-2034年全球畜牧疫苗市场分析、洞察与预测

  • 市场分析、洞察与预测：按类型
    • 失活
    • 减毒活病毒疫苗
    • 重组
    • 其他的
  • 市场分析、洞察与预测：按动物类型划分
    • 牛
    • 猪
    • 家禽
    • 其他的
  • 市场分析、洞察与预测：按给药途径
    • 口服
    • 肠外
    • 其他的
  • 市场分析、洞察与预测：按分销管道划分
    • 动物医院
    • 动物诊所
    • 其他的
  • 市场分析、洞察与预测：按地区划分
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美畜牧疫苗市场分析、洞察与预测（2021-2034年）

  • 国家
    • 我们
    • 加拿大

第七章：欧洲畜牧疫苗市场分析、洞察与预测（2021-2034年）

  • 国家
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪地那维亚
    • 其他欧洲国家

第八章：亚太地区畜牧疫苗市场分析、洞察与预测（2021-2034年）

  • 国家
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 东南亚
    • 其他亚太国家

第九章：拉丁美洲畜牧疫苗市场分析、洞察与预测（2021-2034年）

  • 国家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第十章：中东和非洲畜牧疫苗市场分析、洞察与预测（2021-2034年）

  • 国家
    • 南非
    • GCC
    • 其他中东和非洲国家

第十一章 竞争分析

  • 全球市占率分析（2025 年）
  • 公司简介
    • Boehringer Ingelheim International GmbH
    • Virbac
    • Merck Animal Health（Merck & Co., Inc.）
    • Zoetis Services LLC
    • Ceva
    • Elanco
    • Nisseiken Co., Ltd.
    • Neogen Corporation
Product Code: FBI101418

Growth Factors of livestock vaccines Market

The global livestock vaccines market was valued at USD 6.33 billion in 2025 and is projected to grow to USD 6.68 billion in 2026, reaching USD 11.39 billion by 2034, registering a CAGR of 6.9% during the forecast period. North America dominated the market in 2025 with a 46.90% share, driven by a large livestock population, government-backed vaccination programs, and the widespread adoption of advanced vaccines. The U.S. livestock vaccines market is expected to reach USD 4.29 billion by 2032, supported by ongoing R&D initiatives and government efforts to promote animal health.

Market Overview

Livestock vaccines play a crucial role in protecting farm animals from infectious diseases such as foot-and-mouth disease, infectious bovine rhinotracheitis (IBR), Newcastle disease, and porcine reproductive and respiratory syndrome (PRRS). Vaccines are administered through various routes, including parenteral, oral, intranasal, and subcutaneous, and are available in multiple forms such as live attenuated, inactivated, recombinant, and toxoid vaccines. These vaccines help reduce economic losses associated with livestock illnesses and support global food security.

Market Drivers

The market growth is fueled by the rising prevalence of zoonotic diseases, which can transmit from animals to humans, prompting governments and livestock owners to adopt preventive vaccination programs. In the U.S., around 5,000 animal rabies cases are reported annually, with over 90% occurring in wildlife, highlighting the critical need for livestock vaccines. Increasing awareness among farmers about animal healthcare and the benefits of immunization is further contributing to market growth.

R&D initiatives by major players also drive market expansion. Companies are investing in the development of advanced vaccines, such as protein subunit vaccines and recombinant vaccines, to address emerging diseases and enhance immune responses in livestock. For instance, Boehringer Ingelheim introduced VAXXITEK HVT+IBD+ILT, a recombinant vaccine for poultry protection against Marek's disease, infectious bursal disease, and infectious laryngotracheitis.

Market Restraints

Despite growth opportunities, the market faces challenges from adverse effects associated with vaccines. Live-attenuated vaccines may sometimes cause mild reactions, while certain vaccines show limited efficacy against targeted diseases. Such concerns can reduce the adoption rate among livestock owners and temper market growth in some regions.

Market Segmentation

By Type:

  • Live attenuated vaccines dominated the market in 2026 with a 38.93% share, due to strong and long-lasting immune responses.
  • Recombinant vaccines are expected to witness the highest CAGR from 2026 to 2034, driven by innovation and increasing adoption for poultry and swine protection.
  • Inactivated vaccines and others also contribute to market growth.

By Animal Type:

  • Bovine vaccines accounted for the largest share in 2026 at 58%, supported by the increasing global cattle population.
  • Poultry vaccines are projected to grow at the highest CAGR over 2025-2032 due to rising disease prevalence.
  • Swine/porcine vaccines remain significant due to outbreaks of PRRS and swine influenza.

By Route of Administration:

  • Parenteral vaccines held the largest share in 2026 at 67.16%, providing reliable immune responses and rapid onset.
  • Oral vaccines are growing due to innovation and increasing clinical trials.
  • Other routes, such as intranasal, are limited to specific use cases.

By Distribution Channel:

  • Veterinary clinics dominated in 2024 and continue to lead due to growing livestock visits and availability of veterinarians.
  • Veterinary hospitals are expanding, particularly for post-vaccination care.

Regional Insights

North America: Market size of USD 2.97 billion in 2025, projected USD 3.13 billion in 2026, driven by vaccine launches, adoption of advanced products, and large livestock populations. U.S. market projected to reach USD 2.9 billion in 2026.

Europe: Steady growth driven by poultry and swine adoption, zoonotic disease prevalence, and government awareness campaigns. UK and Germany markets projected at USD 0.24 billion and USD 0.33 billion in 2026, respectively.

Asia Pacific: Highest CAGR expected, led by vaccination programs and awareness initiatives in China, India, and Japan. Markets projected at Japan USD 0.25 billion, China USD 0.28 billion, and India USD 0.10 billion in 2026.

Latin America & Middle East & Africa: Growing market share due to increasing livestock diseases, technological vaccine launches, and enhanced animal healthcare infrastructure.

Key Market Players

Leading companies include Zoetis Services LLC, Merck Animal Health, Boehringer Ingelheim International GmbH, Virbac, Ceva, Elanco, and HIPRA, focusing on R&D, new product launches, mergers, and market expansion to strengthen their global presence. Strategic initiatives such as partnerships, acquisitions, and novel vaccine development are key for market leadership.

Conclusion

The livestock vaccines market is projected to grow from USD 6.33 billion in 2025 to USD 11.39 billion by 2034, driven by rising zoonotic disease prevalence, government initiatives, R&D investment, and technological advancements in vaccine development. Adoption across bovine, poultry, and swine populations, along with increasing awareness and improved vaccination programs, positions the market for sustained growth globally.

Segmentation

By Type

  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others

By Animal Type

  • Bovine
  • Swine/ Porcine
  • Poultry
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Others

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Others

By Geography

  • North America (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country)
    • U.S.
    • Canada
  • Europe (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country/Sub-region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of the Latin America
  • Middle East & Africa (By Type, Animal Type, By Route of Administration, By Distribution Channel, and By Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Veterinary Vaccination Rates: Key Conditions
  • 4.2. Overview on Vaccination Programs
  • 4.3. Key Industry Developments, Mergers, Acquisitions, Partnerships, etc.
  • 4.4. Impact of COVID-19 Pandemic on Livestock Vaccines Market

5. Global Livestock Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Inactivated
    • 5.1.2. Live Attenuated
    • 5.1.3. Recombinant
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Animal Type
    • 5.2.1. Bovine
    • 5.2.2. Swine/ Porcine
    • 5.2.3. Poultry
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.3.1. Oral
    • 5.3.2. Parenteral
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Veterinary Hospitals
    • 5.4.2. Veterinary Clinics
    • 5.4.3. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Livestock Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Inactivated
    • 6.1.2. Live Attenuated
    • 6.1.3. Recombinant
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Animal Type
    • 6.2.1. Bovine
    • 6.2.2. Swine/ Porcine
    • 6.2.3. Poultry
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.3.1. Oral
    • 6.3.2. Parenteral
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Veterinary Hospitals
    • 6.4.2. Veterinary Clinics
    • 6.4.3. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Livestock Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Inactivated
    • 7.1.2. Live Attenuated
    • 7.1.3. Recombinant
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Animal Type
    • 7.2.1. Bovine
    • 7.2.2. Swine/ Porcine
    • 7.2.3. Poultry
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.3.1. Oral
    • 7.3.2. Parenteral
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Veterinary Hospitals
    • 7.4.2. Veterinary Clinics
    • 7.4.3. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. United Kingdom
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Livestock Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Inactivated
    • 8.1.2. Live Attenuated
    • 8.1.3. Recombinant
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Animal Type
    • 8.2.1. Bovine
    • 8.2.2. Swine/ Porcine
    • 8.2.3. Poultry
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.3.1. Oral
    • 8.3.2. Parenteral
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Veterinary Hospitals
    • 8.4.2. Veterinary Clinics
    • 8.4.3. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. China
    • 8.5.2. India
    • 8.5.3. Japan
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Livestock Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Inactivated
    • 9.1.2. Live Attenuated
    • 9.1.3. Recombinant
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Animal Type
    • 9.2.1. Bovine
    • 9.2.2. Swine/ Porcine
    • 9.2.3. Poultry
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.3.1. Oral
    • 9.3.2. Parenteral
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Veterinary Hospitals
    • 9.4.2. Veterinary Clinics
    • 9.4.3. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Livestock Vaccines Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Inactivated
    • 10.1.2. Live Attenuated
    • 10.1.3. Recombinant
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Animal Type
    • 10.2.1. Bovine
    • 10.2.2. Swine/ Porcine
    • 10.2.3. Poultry
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.3.1. Oral
    • 10.3.2. Parenteral
  • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.4.1. Veterinary Hospitals
    • 10.4.2. Veterinary Clinics
    • 10.4.3. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. South Africa
    • 10.5.2. GCC
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Boehringer Ingelheim International GmbH
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Virbac
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Merck Animal Health (Merck & Co., Inc.)
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Zoetis Services LLC
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Ceva
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Elanco
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Nisseiken Co., Ltd.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Neogen Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Livestock Vaccines Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Livestock Vaccines Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
  • Table 3: Global Livestock Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 4: Global Livestock Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 5: Global Livestock Vaccines Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Livestock Vaccines Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 7: North America Livestock Vaccines Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
  • Table 8: North America Livestock Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 9: North America Livestock Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 10: North America Livestock Vaccines Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Livestock Vaccines Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 12: Europe Livestock Vaccines Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
  • Table 13: Europe Livestock Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 14: Europe Livestock Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 15: Europe Livestock Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Livestock Vaccines Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 17: Asia Pacific Livestock Vaccines Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
  • Table 18: Asia Pacific Livestock Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 19: Asia Pacific Livestock Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 20: Asia Pacific Livestock Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Livestock Vaccines Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 22: Latin America Livestock Vaccines Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
  • Table 23: Latin America Livestock Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 24: Latin America Livestock Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 25: Latin America Livestock Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Livestock Vaccines Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 27: Middle East & Africa Livestock Vaccines Market Revenue (USD billion) Forecast, by Animal Type, 2021-2034
  • Table 28: Middle East & Africa Livestock Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
  • Table 29: Middle East & Africa Livestock Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
  • Table 30: Middle East & Africa Livestock Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Livestock Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Livestock Vaccines Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Livestock Vaccines Market Value Share (%), by Animal Type, 2025 & 2034
  • Figure 4: Global Livestock Vaccines Market Value Share (%), by Route of Administration, 2025 & 2034
  • Figure 5: Global Livestock Vaccines Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 6: Global Livestock Vaccines Market Value (USD billion), by Region, 2025 & 2034
  • Figure 7: North America Livestock Vaccines Market Value (USD billion), by Type, 2025 & 2034
  • Figure 8: North America Livestock Vaccines Market Value Share (%), by Type, 2025
  • Figure 9: North America Livestock Vaccines Market Value (USD billion), by Animal Type, 2025 & 2034
  • Figure 10: North America Livestock Vaccines Market Value Share (%), by Animal Type, 2025
  • Figure 11: North America Livestock Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 12: North America Livestock Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 13: North America Livestock Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 14: North America Livestock Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 15: North America Livestock Vaccines Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Livestock Vaccines Market Value Share (%), By Country, 2025
  • Figure 17: Europe Livestock Vaccines Market Value (USD billion), by Type, 2025 & 2034
  • Figure 18: Europe Livestock Vaccines Market Value Share (%), by Type, 2025
  • Figure 19: Europe Livestock Vaccines Market Value (USD billion), by Animal Type, 2025 & 2034
  • Figure 20: Europe Livestock Vaccines Market Value Share (%), by Animal Type, 2025
  • Figure 21: Europe Livestock Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 22: Europe Livestock Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 23: Europe Livestock Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 24: Europe Livestock Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 25: Europe Livestock Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Livestock Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Livestock Vaccines Market Value (USD billion), by Type, 2025 & 2034
  • Figure 28: Asia Pacific Livestock Vaccines Market Value Share (%), by Type, 2025
  • Figure 29: Asia Pacific Livestock Vaccines Market Value (USD billion), by Animal Type, 2025 & 2034
  • Figure 30: Asia Pacific Livestock Vaccines Market Value Share (%), by Animal Type, 2025
  • Figure 31: Asia Pacific Livestock Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 32: Asia Pacific Livestock Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 33: Asia Pacific Livestock Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 34: Asia Pacific Livestock Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 35: Asia Pacific Livestock Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Livestock Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Livestock Vaccines Market Value (USD billion), by Type, 2025 & 2034
  • Figure 38: Latin America Livestock Vaccines Market Value Share (%), by Type, 2025
  • Figure 39: Latin America Livestock Vaccines Market Value (USD billion), by Animal Type, 2025 & 2034
  • Figure 40: Latin America Livestock Vaccines Market Value Share (%), by Animal Type, 2025
  • Figure 41: Latin America Livestock Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 42: Latin America Livestock Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 43: Latin America Livestock Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 44: Latin America Livestock Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 45: Latin America Livestock Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Livestock Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Livestock Vaccines Market Value (USD billion), by Type, 2025 & 2034
  • Figure 48: Middle East & Africa Livestock Vaccines Market Value Share (%), by Type, 2025
  • Figure 49: Middle East & Africa Livestock Vaccines Market Value (USD billion), by Animal Type, 2025 & 2034
  • Figure 50: Middle East & Africa Livestock Vaccines Market Value Share (%), by Animal Type, 2025
  • Figure 51: Middle East & Africa Livestock Vaccines Market Value (USD billion), by Route of Administration, 2025 & 2034
  • Figure 52: Middle East & Africa Livestock Vaccines Market Value Share (%), by Route of Administration, 2025
  • Figure 53: Middle East & Africa Livestock Vaccines Market Value (USD billion), by Distribution Channel, 2025 & 2034
  • Figure 54: Middle East & Africa Livestock Vaccines Market Value Share (%), by Distribution Channel, 2025
  • Figure 55: Middle East & Africa Livestock Vaccines Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Livestock Vaccines Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Livestock Vaccines Market Share (%), By Company, 2025